1346597-76-9

1346597-76-9 structure

Name: Clopidogrel-MP endo derivative-13C,d3
Chemical Name: {1-[1-(2-Chlorophenyl)-2-methoxy-2-oxoethyl]-4-[(2-{3-[(13C,2H3)methyloxy]phenyl}-2-oxoethyl)sulfanyl]-1,2,5,6-tetrahydro-3-pyridinyl}acetic acid
CAS Number: 1346597-76-9
Molecular Formula: C₂₄₁₃CH₂₃D₃ClNO₆S
Molecular Weight: 508.006
Catalog: Research Areas Others
Create Date: 2018-07-03 06:04:28
Modify Date: 2024-01-10 12:57:44
Clopidogrel-MP endo derivative-13C,d3 is the deuterium and 13C labeled Clopidogrel-MP endo derivative[1].

Name	{1-[1-(2-Chlorophenyl)-2-methoxy-2-oxoethyl]-4-[(2-{3-[(13C,2H3)methyloxy]phenyl}-2-oxoethyl)sulfanyl]-1,2,5,6-tetrahydro-3-pyridinyl}acetic acid
Synonyms	1,3(2H)-Pyridinediacetic acid, α1-(2-chlorophenyl)-5,6-dihydro-4-[[2-[3-(methyl-13C-d3-oxy)phenyl]-2-oxoethyl]thio]-, 1-methyl ester {1-[1-(2-Chlorophenyl)-2-methoxy-2-oxoethyl]-4-[(2-{3-[(13C,2H3)methyloxy]phenyl}-2-oxoethyl)sulfanyl]-1,2,5,6-tetrahydro-3-pyridinyl}acetic acid

Description	Clopidogrel-MP endo derivative-13C,d3 is the deuterium and 13C labeled Clopidogrel-MP endo derivative[1].
Related Catalog	Research Areas >> Others Signaling Pathways >> Others >> Others
In Vitro	Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[1].
References	[1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53(2):211-216.